Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FHJU9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,168
Award facts
- Contract value 100% obligated
- $33,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,168.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on November 14, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award was executed without any identified subcontractors, with DMS Pharmaceutical Group serving as the sole prime contractor responsible for pharmaceutical supply and delivery.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical support to Department of Defense military healthcare facilities worldwide. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, and includes a 30-month base period plus three 30-month option periods. Through this vehicle, DLA issues firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and medical consumables to support the recurring pharmaceutical needs of the military medical system globally.
Quick answers
Who was awarded contract SPE2DR26FHJU9?
SPE2DR26FHJU9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FHJU9 worth?
The government has obligated $33,168 on SPE2DR26FHJU9.
Is contract SPE2DR26FHJU9 an order under another contract?
Yes. SPE2DR26FHJU9 is a delivery order under SPE2DR25D9218, an indefinite delivery contract.
Was contract SPE2DR26FHJU9 competed?
The extent of competition for SPE2DR26FHJU9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award